Plantz.io Launches Cannavec.ai — The World’s First Evidence-Based Cannabis Knowledge API

Announced at Cannabis Europa Paris, Cannavec.ai gives clinics, technology platforms, brands and researchers instant access to a vast, continuously updated cannabis knowledge base — via a simple API.

Paris, 19 February 2026 — Plantz.io, the UK-based evidence-based cannabis platform, today announces the launch of Cannavec.ai, a commercial API service that makes the Cannabis Knowledge Foundation’s verified knowledge base available to businesses across the global cannabis industry. The launch is being announced at Cannabis Europa Paris, one of Europe’s leading medical cannabis conferences.

Cannavec.ai is powered by the Cannabis Knowledge Foundation (CKF), an editorially independent body comprised of medical cannabis patients and industry experts. The Foundation oversees a comprehensive vector store knowledge base built by Plantz, covering the pharmacology of the cannabis plant, medical and therapeutic use, evidence and clinical validation, regulation, law and compliance, and culture, history and industry. The same knowledge base already powers ‘Herbie’, the AI assistant on Plantz’s own platform at plantz.io.

A Global Resource, Accessible via API

The knowledge base is designed as a global resource, covering all countries where medical cannabis is legal and regulated. It is accessible via a simple API, enabling companies to build their own AI-powered services on top of a trusted, evidence-based foundation. From patient-facing apps to clinical decision-support tools, Cannavec.ai provides the intelligence layer that cannabis businesses need — without the cost and complexity of building a proprietary knowledge base from scratch.

The knowledge base has access to thousands of clinical studies, enabling doctors and researchers to retrieve the very latest evidence to support patient care. It represents a new paradigm for the industry: rather than every company investing significant time and resources to build and maintain their own knowledge infrastructure, they can integrate Cannavec.ai and focus on what they do best.

Continuously Updated, Human Validated

Unlike static databases, the Cannabis Knowledge Foundation’s knowledge base is continuously updated using a combination of expert editors and dedicated AI research agents that work around the clock to identify, retrieve and process new information from clinical literature, regulatory developments and industry sources. Crucially, all knowledge is validated by humans before publication, ensuring accuracy and maintaining the editorial standards set by the Foundation.

The Foundation’s editorial board includes patients, advocates and data scientists with deep expertise in medical cannabis. This governance model ensures that the knowledge base remains impartial and free from commercial influence — a critical requirement in a sector where trust is essential.

Built for the Industry, With Patients at Its Heart

Cannavec.ai is available across multiple pricing tiers, from enterprise plans for large organisations to start-up and advocacy plans for smaller teams. Recognising the vital role of patient communities, Plantz offers discounted rates to non-profit patient groups, ensuring that the people who stand to benefit most from better cannabis knowledge are not priced out.

Founder’s Statement

“The Cannabis Knowledge Foundation is a revolution in healthcare. A vector store knowledge base is at the heart of AI and enables patients, clinics and the full cannabis supply chain to access a vast amount of research. It represents a vision of the future where companies can build their own services on top of a knowledge base that is evidence based and governed by an independent editorial team, meaning users can be confident in the impartiality of the information. It’s taken over a year to build but is now available for pioneering businesses who are powering the advance of medical cannabis as an important treatment for conditions such as multiple sclerosis, fibromyalgia, epilepsy and chronic pain.”

— Neil Cartwright, Co-Founder, Plantz

Editor’s Statement

“I am extremely proud and honoured, in my capacity as both a patient and industry expert, to be working with Plantz.io and the exceptional team, assembled to support and develop its AI system. Being able to contribute a well-rounded perspective that reflects both patient needs and industry requirements marks an important step forward. This is a truly ground-breaking moment for the industry.

— Chris Hobday

— ENDS —

Notes to Editors

About Plantz: Plantz (plantz.io) is a UK-based evidence-based natural remedies and medical cannabis platform. Plantz educates and empowers patients through science-backed content, AI-powered tools, and community. Its AI assistant ‘Herbie’ provides patients with evidence-based answers to their cannabis questions.

About the Cannabis Knowledge Foundation: The Cannabis Knowledge Foundation (CKF) is an editorially independent body that governs the cannabis knowledge base. Its editorial board is comprised of medical cannabis patients, advocates and experts. The Foundation ensures that all knowledge is evidence-based, transparently sourced, and free from commercial influence. The CKF maintains a constitutional separation between knowledge governance and commercial licensing.

About Cannavec.ai: Cannavec.ai is the commercial API service for the Cannabis Knowledge Foundation’s knowledge base. It provides verified, evidence-based cannabis science to clinics, technology platforms, brands and researchers via a simple REST API. More information at cannavec.ai.

About Cannabis Europa: Cannabis Europa is one of Europe’s leading medical cannabis conferences, bringing together industry leaders, clinicians, policymakers and patient advocates. The Paris 2026 event takes place on 19 February at the Hôtel de l’Industrie. More information at cannabis-europa.com.

About Christopher P. Hobday: Christopher P. Hobday has been an integral part of the United Patients Alliance for well over a decade, including during its formative founding years. His longstanding commitment to patient advocacy has positioned him as a respected voice within both the patient community and the wider industry.

Christopher lives with Complex Regional Pain Syndrome (CRPS), a severe and highly complex chronic pain condition involving neurological and autoimmune components. His lived experience with this debilitating condition has informed his advocacy work and strengthened his dedication to improving patient access, understanding, and policy development within the sector.

Media Contact

Neil Cartwright, Co-Founder, Plantz

Web: plantz.io | cannavec.ai

Media Partner: Newsweed.fr